CHRIS AMOS to Glioma
This is a "connection" page, showing publications CHRIS AMOS has written about Glioma.
Connection Strength
1.695
-
The genomic landscape of familial glioma. Sci Adv. 2023 04 28; 9(17):eade2675.
Score: 0.142
-
Influence of county-level geographic/ancestral origin on glioma incidence and outcomes in US Hispanics. Neuro Oncol. 2023 02 14; 25(2):398-406.
Score: 0.140
-
Partitioned glioma heritability shows subtype-specific enrichment in immune cells. Neuro Oncol. 2021 08 02; 23(8):1304-1314.
Score: 0.126
-
Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics. Int J Cancer. 2020 02 01; 146(3):739-748.
Score: 0.107
-
Sex-specific gene and pathway modeling of inherited glioma risk. Neuro Oncol. 2019 01 01; 21(1):71-82.
Score: 0.105
-
Aspirin, NSAIDs, and Glioma Risk: Original Data from the Glioma International Case-Control Study and a Meta-analysis. Cancer Epidemiol Biomarkers Prev. 2019 03; 28(3):555-562.
Score: 0.104
-
Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21. Sci Rep. 2018 05 09; 8(1):7352.
Score: 0.100
-
Glioma-related seizures in relation to histopathological subtypes: a report from the glioma international case-control study. J Neurol. 2018 Jun; 265(6):1432-1442.
Score: 0.100
-
Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors. Nat Genet. 2017 May; 49(5):789-794.
Score: 0.093
-
History of chickenpox in glioma risk: a report from the glioma international case-control study (GICC). Cancer Med. 2016 06; 5(6):1352-8.
Score: 0.086
-
Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study. Cancer Epidemiol Biomarkers Prev. 2016 Feb; 25(2):282-90.
Score: 0.086
-
The Glioma International Case-Control Study: A Report From the Genetic Epidemiology of Glioma International Consortium. Am J Epidemiol. 2016 Jan 15; 183(2):85-91.
Score: 0.085
-
Targeted sequencing in chromosome 17q linkage region identifies familial glioma candidates in the Gliogene Consortium. Sci Rep. 2015 Feb 05; 5:8278.
Score: 0.080
-
Germline mutations in shelterin complex genes are associated with familial glioma. J Natl Cancer Inst. 2015 Jan; 107(1):384.
Score: 0.079
-
Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium. Eur J Cancer. 2013 Apr; 49(6):1335-45.
Score: 0.069
-
A variable age of onset segregation model for linkage analysis, with correction for ascertainment, applied to glioma. Cancer Epidemiol Biomarkers Prev. 2012 Dec; 21(12):2242-51.
Score: 0.068
-
Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma. Hum Genet. 2012 Sep; 131(9):1507-17.
Score: 0.067
-
Segregation analysis of cancer in families of glioma patients. Genet Epidemiol. 2001 Feb; 20(2):258-70.
Score: 0.030
-
Comparison of pathway and gene-level models for cancer prognosis prediction. BMC Bioinformatics. 2020 Feb 28; 21(1):76.
Score: 0.028